Spark Therapeutics sparktx.com

Spark Therapeutics is developing curative, one-time gene therapy products with the potential to transform the lives of patients and re-imagine the treatment of debilitating diseases. Spark's lead gene therapy candidate, for RPE65-related blindness, is currently in Phase 3 clinical trials with the potential to be the first approved gene therapy in the United States, and the first treatment to address the significant unmet needs of patients living with blindness due to inherited retinal dystrophie...Show all

Spark Therapeutics is developing curative, one-time gene therapy products with the potential to transform the lives of patients and re-imagine the treatment of debilitating diseases. Spark's lead gene therapy candidate, for RPE65-related blindness, i...Show all

See All Exits Recent Exits

Phone: 855-772-7589

Fax:

3737 Market Street
Suite 1300
Philadelphia, 19104
Pennsylvania, United States

Spark Therapeutics - Investments & Acquisitions

Show Real Data Spark Therapeutics Investments
See all Recent Investments
Date Company Round Amount Co-investors
2016-03-07Genable TechnologiesAcquired
See all 1 investments